Cancer Archive — Page 49 of 71

February 2, 2017

New target for chronic infection

An enzyme in macrophage immune cells may be a good target for treating chronic infections, Vanderbilt researchers have discovered.

Illustration of human intestinal tract
January 19, 2017

Colorectal cancer clues

Although cancers arising from different areas of the large intestine are heterogeneous, they appear to use similar important tumorigenic pathways.

Professional headshot of a smiling woman with shoulder-length brown hair wearing a black blazer.
January 19, 2017

VICC joins cancer genomic data sharing initiative

Vanderbilt-Ingram Cancer Center (VICC) has joined an international consortium of leading cancer centers to share genomic data from patients in an effort to accelerate the pace of cancer research and improve precision medicine.

Hacker typing on a laptop
January 19, 2017

Metastatic pancreatic cancer ‘reprograms’ for malignancy

Metastatic pancreatic cancer — cancer that has spread from the pancreas to other tissues and is responsible for most patient deaths — changes its metabolism and is “reprogrammed” for optimal malignancy, according to new findings reported Jan. 16 in Nature Genetics.

Hand holding a small vaccine vial labeled “1 DOSE VIAL 0.5 mL,” “Quadrivalent Human Papillomavirus Types 6, 11, 16, 18,” “Recombinant Vaccine,” and “GARDASIL,” with a lot number and expiration details visible but too small to read.
January 17, 2017

Vanderbilt-Ingram Cancer Center supports national HPV vaccination efforts

Nearly 39,000 new cancers associated with the human papillomavirus (HPV) will be diagnosed in the United States this year. Although HPV vaccines can prevent the majority of these cancers, vaccination rates remain low across the country.

color-enhanced cross section of tumor tissue
January 16, 2017

Softening tumor tissue could aid cancer treatments

Tumors cause the intracellular material surrounding them to stiffen. Softening this protective layer could make existing cancer treatments more effective, according to new research.